Posts Tagged ‘phase’
Phase 3 Study of VX-770 have shown? of the amendment? improvement of the function is deep and lasting lung (FEV1) and other measures. . .
February 27th, 2011 | 
Author: Phase 3 Study of VX-770 Showed Profound and Sustained Improvements in Lung Function (FEV1) and Other Measures of …
Vertex Pharmaceuticals Incorporated today announced positive results from the Phase 3 STRIVE study of VX-770, an oral medicine in development that targets the defective protein that causes cystic fibrosis .
Read more on Business Wire via Yahoo! Finance
Related Blogs
- The cystic fibrosis victim who defied doctors and took off around …
- Washington State Business Wire » Kids and Families Come Last …
- “Hide away in Rockford” [Darleen Click] – protein wisdom
- “New Study Shows That Offshore Drilling Could Make Alaska the …
- Cystic Fibrosis Causes, Symptoms and Treatments | HEALTH NEWS FROM …
Posted in Affiliate Programs | 
Tags: amendment, deep, FEV1, Function, Improvement, lasting, Lung, measures, phase, shown, study, VX770 | 
No Comments »
Seattle Genetics and Mill? Millennium report data? If Phase II registration pending initial positive Vedotin Brentuximab (SGN-35) if RecA? Da. . .
Seattle Genetics and Millennium Report Positive Data from Phase II Trial of Brentuximab Vedotin (SGN-35) in Relapsed …
ORLANDO, Fla.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced positive data from a phase II clinical trial of single-agent brentuximab vedotin (SGN-35) in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). Brentuximab vedotin is …
Read more on Business Wire
Related Blogs
- Spherix Phase 2 diabetes clinical trial determines minimum D …
- Seattle Genetics, Millennium Report Groundbreaking Results With …
- Seattle Genetics, Inc. (NASDAQ: SGEN) Given “Buy” Rating by …
- Reese Pharmaceutical Company Announces the Voluntary Nationwide …
- Phase II – www.basildawkins.com – oDesk | Freelance Jobs
Posted in Work From Home |
Tags: Brentuximab, Data, Genetics, initial, Mill, Millennium, pending, phase, Positive, RecA, registration, Report, Seattle, SGN35, Vedotin |
1 Comment »
CVBT licenses Phase II data? Back diab? Policy scarring? No wound? Merck
CVBT Licenses Phase II Diabetic Wound Healing Data From Merck
CardioVascular BioTherapeutics Inc. today announced the successful closing of an exclusive licensing agreement with an affiliate of Merck & Co., Inc., for clinical and scientific data regarding the therapeutic use of human fibroblast growth factor-1 for the treatment of diabetic wounds, including Phase IIa and IIb data.
Read more on PR Newswire via Yahoo! Finance
Seattle Genetics and Agensys, a subsidiary of Astellas Announce Opening of Phase I clinical trials ASG-fifth. . .
Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Initiation of Phase I Clinical Trial of ASG-5ME for …
BOTHELL, Wash.—-Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer.
Read more on Business Wire via Yahoo! Finance
Related Blogs
- SiteGround Selects The Planet Server Cloud – Business Wire (press …
- Angelina Jolie scolds Maddox in Tokyo airport | HollywoodNews.com
- Seattle Genetics Inc. (SGEN) goes negative by breaking below …
- Pancreatic Cancer Drug: Seattle Genetics and Partner Agensys Start …
- More Information on Research and Clinical Trials « Autism Speaks …
Posted in Affiliate Programs |
Tags: Agensys, Announce, ASGfifth., Astellas, Clinical, Genetics, Opening, phase, Seattle, subsidiary, Trials |
No Comments »
Johnson & Johnson Pharmaceutical Research & Development Reports Phase 2b Clinical Trial Results Evaluating . . .
Johnson & Johnson Pharmaceutical Research & Development Reports Phase 2b Clinical Trial Results Evaluating …
ORLANDO, Fla., June 26 /PRNewswire/ — Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Read more on redOrbit
Related Blogs
Posted in Affiliate Programs |
Tags: Clinical, development, Evaluating, Johnson, Pharmaceutical, phase, Reports, Research, Results, Trial. |
1 Comment »
American Water Resources entered a new phase with wood donated to Habitat for Humanity
American Water Resources Marks Milestone with Lumber Donation to Habitat for Humanity
VOORHEES, N.J.—-American Water Resources, Inc., a subsidiary of American Water Works Company, Inc. , the largest investor-owned U.S. water and wastewater utility company, today marked its achievement of 750,000 customer contracts by donating 750 pieces of lumber to Metropolitan Camden Habitat for Humanity.
Read more on Business Wire via Yahoo! Finance
